Abbas Hussain Joins the Board of Immunocore as Non-Executive Director
Ian T. Clark also appointed as special adviser to the Board
Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases, announced today that Abbas Hussain has joined the Board of Directors as a Non-Executive Director. Ian T. Clark has also joined as a special adviser to the Board of Immunocore. Abbas Hussain was most recently President of Global Pharmaceuticals at GlaxoSmithKline (GSK), where he had overall responsibility for the Company’s sales business, and led operations supporting commercial infrastructure including medical, finance, human resources, IT, legal and communications. Abbas chaired GSK’s pharmaceutical operations committee, driving key decisions on commercial strategy, and was on the Board of ViiV Healthcare Ltd., GSK’s HIV-specialised business unit.